<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2023_1_62</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-120</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Анализ ассоциации полиморфизма гена репарации ДНК APEX1 с развитием подагры</article-title><trans-title-group xml:lang="en"><trans-title>Associations of the APEX1 T444G DNA repair gene with the gout development</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мишко</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Mishko</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; Gorky str., 39A; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кушнаренко</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kushnarenko</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; Gorky str., 39A; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Медведева</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Medvedeva</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>108814; ул. Сосненский стан, дом 8, стр. 11; Москва</p></bio><bio xml:lang="en"><p>108814; Sosnensky Stan str., 8, building 11; Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироманова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miromanova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; Gorky str., 39A; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Караваева</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Karavaeva</surname><given-names>T. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; Gorky str., 39A; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гайдукова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gaidukova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000; ул. Горького, 39а; Чита</p></bio><bio xml:lang="en"><p>672000; Gorky str., 39A; Chita</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Читинская государственная медицинская академия» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Московский многопрофильный клинический центр «Коммунарка»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Multidisciplinary Clinical Center "Kommunarka"</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>1</issue><fpage>62</fpage><lpage>73</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мишко М.Ю., Кушнаренко Н.Н., Медведева Т.А., Мироманова Н.А., Караваева Т.М., Гайдукова Т.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Мишко М.Ю., Кушнаренко Н.Н., Медведева Т.А., Мироманова Н.А., Караваева Т.М., Гайдукова Т.В.</copyright-holder><copyright-holder xml:lang="en">Mishko M.Y., Kushnarenko N.N., Medvedeva T.A., Miromanova N.A., Karavaeva T.M., Gaidukova T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/120">https://www.zabmedvestnik.ru/jour/article/view/120</self-uri><abstract><sec><title>   Цель исследования</title><p>   Цель исследования. Изучить распределение частот аллелей и генотипов полиморфного локуса T444G rs1130409 гена репарации ДНК APEX1 у больных подагрой и оценить их ассоциацию с вероятностью развития заболевания в популяции русских Забайкальского края.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы. Обследовано 80 пациентов (69 мужчин и 11 женщин) с подагрой. Диагноз подагры выставлен согласно классификационным критериям ACR/EULAR, 2015. Контрольную группу составили 46 здоровых лиц соответствующего возраста. По национальной принадлежности все обследуемые являлись русскими, родившимися и проживающими на территории Забайкальского края. Материалом для исследования являлась ДНК, выделенная из лейкоцитов цельной периферической крови с использованием комплекта реагентов «ДНК-Экспресс Кровь» («Литех», Россия). Все пациенты были генотипированы для выявления полиморфизма локуса T444G rs1130409 гена APEX1. Статистическая обработка данных проводилась с помощью пакета статистических программ Statistica 10,0. Распределение генотипов проверяли на соответствие равновесию Харди-Вайнберга с помощью критерия χ2. Различия по частоте аллелей и генотипов между группами оценены критерием χ2 Пирсона. Для оценки ассоциации генотипов и аллелей с подагрой рассчитаны показатели отношения шансов (Odds Ratio, OR) с оценкой 95 %-ного доверительного интервала (Confidence Interval, CI).</p></sec><sec><title>   Результаты</title><p>   Результаты. При исследовании полиморфизма T444G гена APEX1 у больных подагрой обнаружено статистически значимое увеличение частоты гомозиготного генотипа G/G (27,5 % против 9 %; χ2 = 6,3; p = 0,01; OR = 3,98; CI95 % = 1,28-12,4). В группе больных подагрой мужского пола отмечается более высокая частота мутантного аллеля G по сравнению с контрольной группой (53,6 % против 4 %; χ2 = 5,66; р = 0,01; OR = 2,24; CI95 % = 1,14-4,40) и статистически значимое уменьшение частоты аллеля Т (46,4 % против 96 % соответственно; χ2 = 5,66, р = 0,01, OR = 0,45, CI95 % = 0,23-0,87).</p></sec><sec><title>   Заключение</title><p>   Заключение. Обнаружены различия в распределении частот аллелей и генотипов полиморфного локуса APEX1 T444G rs1130409 у больных подагрой и здоровых респондентов. Наличие генотипа G/G повышает вероятность подагры в 3,9 раза. У респондентов мужского пола носительство аллеля дикого типа (T) оказывает протективное влияние, в то время как носительство минорного аллеля было ассоциировано с увеличением вероятности развития заболевания. Полученные данные указывают на возможную роль полиморфизма гена APEX1 T444G rs1130409 в патогенезе развития подагры.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Objective</title><p>   Objective. To study the frequencies of alleles and genotypes of the polymorphic locus T444G rs1130409 of the APEX1 DNA repair gene in patients with gout and to evaluate their association with the gout development in the Russian population in the Trans-Baikal Territory.</p></sec><sec><title>   Materials and methods</title><p>   Materials and methods. 80 patients (69 men and 11 women) with gout were examined. The diagnosis of gout was made in accordance with the ACR/EULAR classification criteria, 2015. The control group consisted of 46 persons of the appropriate age. According to nationality all the subjects were Russians, born and living in the territory of the Trans-Baikal Territory. The material for the study was DNA isolated from whole peripheral blood leukocytes using the DNA-Express Blood kit (Litech, Russia). All patients were genotyped to determine the polymorphism of the T444G rs1130409 locus of the APEX1 gene. Statistical data processing was carried out using the Statistica 10.0 software registry. The correspondence of genotype distribution to the Hardy-Weinberg equilibrium was checked by χ2 criterion. Differences in the frequency of alleles and genotypes between groups were assessed by Pearson's χ2 test. To assess the association of genotypes and alleles with gout, high odds ratios (Odds Ratio, OR) were calculated with a 95 % confidence interval (Confidence Interval, CI).</p></sec><sec><title>   Results</title><p>   Results. In the study of T444G polymorphism of the APEX1 gene in patients with gout a statistically significant increase in the frequency of the homozygous genotype G/G (27.5 % vs. 9 %; χ2 = 6.3; p = 0.01; OR = 3.98; CI 95 % = 1.28 -12.4) were found. In the group of male patients with gout, there is a higher frequency of the mutant G allele compared to the control group (53.6 % vs. 4 %; χ2 = 5.66; p = 0.01; OR = 2.24; CI95 % = 1, 14-4.40) and a statistically significant decrease in the frequency of the T allele (46.4 % vs. 96 %; χ2 = 5.66, p = 0.01, OR = 0.45, CI95 % = 0.23-0, 87).</p></sec><sec><title>   Conclusion</title><p>   Conclusion. Differences were found in the distribution of allele and genotype frequencies of the APEX1 T444G rs1130409 polymorphic locus in patients with gout and healthy respondents. The presence of the G/G genotype G increases the risk of gout by 3.9 times respectively. In male respondents, the carriage of the wild-type (T) allele has a protective effect, while the carriage of the minor allele was associated with an increased likelihood of developing the disease. The data obtained indicate the possible role of the APEX1 T444G rs1130409 gene polymorphism in the pathogenesis of gout.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>мочевая кислота</kwd><kwd>генетический полиморфизм</kwd><kwd>APEX1</kwd><kwd>гены пуринового обмена</kwd><kwd>гены репарации ДНК</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>uric acid</kwd><kwd>genetic polymorphism</kwd><kwd>APEX1</kwd><kwd>purine metabolism genes</kwd><kwd>DNA repair genes</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава РФ в рамках утвержденного плана НИР</funding-statement><funding-statement xml:lang="en">The work was carried out with financial support FSBEI HE "Chita State Medical Academy" of the Ministry of Health of the Russian Federation within the framework of approved research plan</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Сухих Ж.Л., Штонда М.В., Петров С.А., Воробьева Е.П. Подагра: современные аспекты диагностики и лечения. Международные обзоры: клиническая практика и здоровье. 2014. 5(11). 79-89.</mixed-citation><mixed-citation xml:lang="en">Suhih Zh.L., Shtonda M.V., Petrov S.A., Vorob'eva E.P. Gout: modern aspects of diagnosis and treatment. Mezhdunarodnye obzory: klinicheskaja praktika i zdorov'e. 2014. 5(11). 79-89. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Денисов И.С., Елисеев М.С., Барскова В.Г. Исходы подагры. Обзор литературы. Часть I. Эпидемиология подагры, факторы риска и течение заболевания с развитием хронической тофусной формы. Проблемы практической ревматологии. 2013. 51(5). 569-573. URL: https://rsp.mediar-press.net/rsp/article/view/1677?locale=ru_RU.</mixed-citation><mixed-citation xml:lang="en">Denisov I.S., Eliseev M.S., Barskova V.G. Gout outcomes. A review of literature. Part 1. Gout: Epidemiology, risk factors, course of the disease with the development of chronic tophus form. Rheumatology Science and Practice. 2013. 51(5). 569-573. URL: https://rsp.mediar-press.net/rsp/article/view/1677?locale=ru_RU.. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Цурко В.В., Громова М.А., Червякова Ю.Б., Копелев А.А. Гиперурикемия и сердечно-сосудистые заболевания: современные аспекты терапии. Лечебное дело. 2019. 1. 14-19. DOI: 10.24411/2071-5315-2019-12085.</mixed-citation><mixed-citation xml:lang="en">Tsurko V.V., Gromova M.A., Chervyakova Yu.B., Kopelev A.A. Hyperuricemia and Cardiovascular Diseases: Modern Aspects of Therapy. Lechebnoe delo. 2019. 1. 14-19. URL: 10.24411/2071-5315-2019-12085. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Денисов И.С., Елисеев М.С., Барскова В.Г. Исходы подагры. Обзор литературы. Часть II. Коморбидные заболевания, риск развития сердечно-сосудистых катастроф и смерти при подагре. Проблемы практической ревматологии. 2013. 51(6). 703-710. URL: https://rsp.mediar-press.net/rsp/article/view/1683.</mixed-citation><mixed-citation xml:lang="en">Denisov I.S., Eliseev M.S.., Barskova VG. Gout outcomes. Literature review. Part II. Comorbid diseases, risk of developing cardiovascular catastrophes and death in gout patients. Rheumatology Science and Practice. 2013. 51(6). 703-710. URL: https://rsp.mediar-press.net/rsp/article/view/1683.. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ледяхова М.В., Насонова С.Н., Терещенко С.Н. Гиперурикемия как предиктор хронической сердечной недостаточности. Рациональная фармакотерапия в кардиологии. 2015. 11(4). 355-358. DOI: 10.20996/1819-6446-2015-11-4-355-358.</mixed-citation><mixed-citation xml:lang="en">Ledyakhova M.V., Nasonova S.N., Tereshchenko S.N. Hyperuricemia as a predictor of chronic heart failure. Ration Pharmacother Cardiol. 2015. 11(4). 355-358. DOI: 10.20996/1819-6446-2015-11-4-355-358. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Singh J.A., Gaffo A. Gout epidemiology and comorbidities/ Semin Arthritis Rheum. 2020. 50 (3S). S11-S16. DOI 10.1016/j.semarthrit.2020.04.008.</mixed-citation><mixed-citation xml:lang="en">Singh J.A., Gaffo A. Gout epidemiology and comorbidities/ Semin Arthritis Rheum. 2020. 50 (3S). S11-S16. DOI: 10.1016/j.semarthrit.2020.04.008.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеев М.С., Новикова А.М. Коморбидность при подагре и гиперурикемии: распространенность, причины, перспективы уратснижающей терапии. Терапевтический архив. 2019. 91(5). 120-128. DOI 10.26442/00403660.2019.05.000232.</mixed-citation><mixed-citation xml:lang="en">Eliseev M.S., Novikova A.M. Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy. Therapeutic Archive. 2019. 91(5). 120-128. DOI: 10.26442/00403660.2019.05.000232. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Merriman T.R. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther. 2015. 17 (1). 98. URL: https://www.researchgate.net/publication/274838354_An_update_on_the_genetic_architecture_of_hyperuricemia_and_gout.</mixed-citation><mixed-citation xml:lang="en">Merriman T.R. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther. 2015. 17 (1). 98. URL: https://www.researchgate.net/publication/274838354_An_update_on_the_genetic_architecture_of_hyperuricemia_and_gout.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng M., Ma J.W. Research progress in the genetics of hyperuricaemia and gout. Yi Chuan. 2016 Apr. 38(4). 300-13. DOI: 10.16288/j.yczz.15-385.</mixed-citation><mixed-citation xml:lang="en">Zheng M., Ma J.W. Research progress in the genetics of hyperuricaemia and gout. Yi Chuan. 2016 Apr. 38(4). 300-13. DOI: 10.16288/j.yczz.15-385.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C.J., Tseng C.C., Yen J.H., et al. ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study. Sci Rep. 2018. 8(1). 3137. DOI: 10.1038/s41598-018-21425-7.</mixed-citation><mixed-citation xml:lang="en">Chen C.J., Tseng C.C., Yen J.H., et al. ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study. Sci Rep. 2018. 8(1). 3137. DOI: 10.1038/s41598-018-21425-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nakatochi M., Kanai M., Nakayama A., et al. Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals. Commun Biol. 2019. 2. 115. DOI: 10.1038/s42003-019-0339-0.</mixed-citation><mixed-citation xml:lang="en">Nakatochi M., Kanai M., Nakayama A., et al. Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals. Commun Biol. 2019. 2. 115. DOI: 10.1038/s42003-019-0339-0.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кушнаренко Н.Н., Мишко М.Ю., Медведева Т.А., Витковский Ю.А. Полиморфизм гена АВСG2 у больных подагрой в Забайкальском крае. Комплексные проблемы сердечно-сосудистых заболеваний. 2019. 8(2). 77-86. DOI: 10.17802/2306-1278-2019-8-2-77-86.</mixed-citation><mixed-citation xml:lang="en">Kushnarenko N.N., Mishko M.Yu., Medvedeva T.A., Vitkovsky Yu.A. ABCG2 gene polymorphism in patients with gout in Zabaikalsky krai. Complex Issues of Cardiovascular Diseases. 2019. 8(2). 77-86. DOI: 10.17802/2306-1278-2019-8-2-77-86. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Мишко М.Ю., Кушнаренко Н.Н., Медведева Т.А. Анализ межгенных взаимодействий, предрасполагающих к развитию подагры в популяции русских Забайкальского края. Забайкальский медицинский вестник : электронное научное издание. 2020. 4. 96-109. URL: https://elibrary.ru/item.asp?id=44600202 (дата обращения: 14. 11. 2022). DOI: 10.52485/19986173_2020_4_96.</mixed-citation><mixed-citation xml:lang="en">Mishko M. Yu., Kushnarenko N. N., Medvedeva T. A. Analysis of intergenic interactions predisposing to gout among the russian population of the Trans-Baikal territory. Zabajkal'skij medicinskij vestnik : jelektronnoe nauchnoe izdanie. 2020. 4. 96-109. URL: https://elibrary.ru/item.asp?id=44600202 (date of the application: 14. 11. 2022). DOI: 10.52485/19986173_2020_4_96. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеев М.С., Чикина М.Н., Гусева И.А., Желябина О.В., Самаркина Е.Ю., Коновалова Н.В., Варламов Д.А. Связь полиморфизма Q141K гена ABCG2 с эффективностью уратснижающей терапии у пациентов с подагрой (пилотное исследование). Современная ревматология. 2021. 15(6). 55-60. DOI: 10.14412/1996-7012-2021-6-55-60.</mixed-citation><mixed-citation xml:lang="en">Eliseev M.S., Chikina M.N., Guseva I.A., Zhelyabina O.V., Samarkina E.Yu., Konovalova N.V., Varlamov D.A. Association of the Q141K polymorphism of the ABCG2 gene with the effectiveness of urate-lowering therapy in patients with gout (a pilot study). Modern Rheumatology Journal. 2021. 15(6). 55-60. DOI: 10.14412/1996-7012-2021-6-55-60. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Peng Q., Lu Y., Lao X. et al. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis. Diagnostic Pathology. 2014. 9. 108. DOI: 10.1186/1746-1596-9-108.</mixed-citation><mixed-citation xml:lang="en">Peng Q., Lu Y., Lao X., et al. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis. Diagnostic Pathology. 2014. 9. 108. DOI: 10.1186/1746-1596-9-108.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Das S., Nath S., Bhowmik A., Ghosh S.K., Choudhry Y. Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a metaanalysis. SpringerPlus. 2016. 5. 227. DOI: 10.1186/s40064-016-1858-5.</mixed-citation><mixed-citation xml:lang="en">Das S., Nath S., Bhowmik A., Ghosh S.K., Choudhry Y. Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers: a metaanalysis. SpringerPlus. 2016. 5. 227. DOI: 10.1186/s40064-016-1858-5.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Naganuma T., Nakayama T., Sato N., et al. Haplotype-Based Case–Control Study on Human Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Gene and Essential Hypertension. American Journal of Hypertension. 2010. 23(2). 186-191. DOI: 10.1038/ajh.2009.221.</mixed-citation><mixed-citation xml:lang="en">Naganuma T., Nakayama T., Sato N., et al. Haplotype-Based Case–Control Study on Human Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Gene and Essential Hypertension. American Journal of Hypertension. 2010. 23(2). 186-191. DOI: 10.1038/ajh.2009.221.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Das S., Purkayastha S., Roy H., Sinha A., Choudhry Y. Polymorphisms in DNA repair genes increase the risk for type 2 diabetes mellitus and hypertension. BioMol Concepts. 2018. 9. 80-93. DOI: 10.1515/bmc-2018-0008.</mixed-citation><mixed-citation xml:lang="en">Das S., Purkayastha S., Roy H., Sinha A., Choudhry Y. Polymorphisms in DNA repair genes increase the risk for type 2 diabetes mellitus and hypertension. BioMol Concepts. 2018. 9. 80-93. DOI: 10.1515/bmc-2018-0008.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Кушнаренко Н.Н. Сердечно-сосудистые нарушения у мужчин с подагрой: клинические особенности, механизмы развития, прогнозирование [диссертация … док. мед. наук]. Чита: ГОУ ВПО «Читинская государственная медицинская академия». 2012.</mixed-citation><mixed-citation xml:lang="en">Kushnarenko N.N. Cardiovascular disorders in men with gout: clinical features, mechanisms of development, prognosis [dissertation]. Chita. Chita State Medical Academy. 2012. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Кушнаренко Н.Н., Медведева Т.А., Говорин А.В., Мишко М.Ю. Роль изменений жирно-кислотного состава мембран эритроцитов в формировании нарушений кардиогемодинамики у больных подагрой с синдромом инсулинорезистентности. Российский кардиологический журнал. 2018. 23(5). 49-55. DOI: 10.15829/1560-4071-2018-5-49-55.</mixed-citation><mixed-citation xml:lang="en">Kushnarenko N.N., Medvedeva T.A., Govorin A.V., Mishko M.Yu. The role of fatty acid contents of erythrocytes membranes in cardiohemodynamics disorder in gout patients with insulin resistance syndrome. Russian Journal of Cardiology. 2018. 23(5). 49-55. DOI: 10.15829/1560-4071-2018-5-49-55. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018. 484. 150-163. DOI: 10.1016/j.cca.2018.05.046.</mixed-citation><mixed-citation xml:lang="en">Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018. 484. 150-163. DOI: 10.1016/j.cca.2018.05.046.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Maiuolo J., Oppedisano F., Gratteri S., Muscoli C., Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016. 213. 8-14. DOI: 10.1016/j.ijcard.2015.08.109.</mixed-citation><mixed-citation xml:lang="en">Maiuolo J., Oppedisano F., Gratteri S., Muscoli C., Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016. 213. 8-14. DOI: 10.1016/j.ijcard.2015.08.109.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Дырхеева Н.С., Лебедева Н.А., Лаврик О.И. АР эндонуклеаза 1 – ключевой фермент репарации апуриновых/апиримидиновых сайтов. Обзор. Биохимия. 2016. 81(9). 1198-1216.</mixed-citation><mixed-citation xml:lang="en">Dyrkheeva N.S., Lebedeva N.A., Lavrik O.I. AP endonuclease 1 is a key enzyme in repair of apurine/apyrimidine sites. Review. Biochemistry. 2016. 81(9). 1198-1216. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chatterjee N., Walker G.C. Mechanisms of DNA damage, repair, and mutagenesis. Environ Mol Mutagen. 2017. 58(5). 235-263. DOI: 10.1002/em.22087.</mixed-citation><mixed-citation xml:lang="en">Chatterjee N., Walker G.C. Mechanisms of DNA damage, repair, and mutagenesis. Environ Mol Mutagen. 2017. 58(5). 235-263. DOI: 10.1002/em.22087.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bokhari В., Sharma S. Stress Marks on the Genome: Use or Lose? Int J Mol Sci. 2019. 20(2). 364. DOI: 10.3390/ijms20020364.</mixed-citation><mixed-citation xml:lang="en">Bokhari В., Sharma S. Stress Marks on the Genome: Use or Lose? Int J Mol Sci. 2019. 20(2). 364. DOI: 10.3390/ijms20020364.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Weber D., Stuetz W., Toussaint O., et al. Associations between Specific Redox Biomarkers and Age in a Large European Cohort: The MARK-AGE Project/ Oxid Med Cell Longev. 2017. 2017. 1401452. DOI: 10.1155/2017/1401452.</mixed-citation><mixed-citation xml:lang="en">Weber D., Stuetz W., Toussaint O., et al. Associations between Specific Redox Biomarkers and Age in a Large European Cohort: The MARK-AGE Project/ Oxid Med Cell Longev. 2017. 2017. 1401452. DOI: 10.1155/2017/1401452.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Luo C., Lian X., Hong L., et al. High Uric Acid Activates the ROS-AMPK Pathway, Impairs CD68 Expression and Inhibits OxLDL-Induced Foam-Cell Formation in a Human Monocytic Cell Line, THP-1. Cell Physiol Biochem. 2016. 40 (3-4). 538-548. DOI: 10.1159/000452567.</mixed-citation><mixed-citation xml:lang="en">Luo C., Lian X., Hong L., et al. High Uric Acid Activates the ROS-AMPK Pathway, Impairs CD68 Expression and Inhibits OxLDL-Induced Foam-Cell Formation in a Human Monocytic Cell Line, THP-1. Cell Physiol Biochem. 2016. 40 (3-4). 538-548. DOI: 10.1159/000452567.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yan Z., Yuan Z., Ni J., Gu L., Shen Y. Crystal structure of the crenarchaeal ExoIII AP endonuclease SisExoIII reveals a conserved disulfide bond endowing the protein with thermostability. Biochem Biophys Res Commun. 2017. 490(3). 774-779. DOI: 10.1016/j.bbrc.2017.06.116.</mixed-citation><mixed-citation xml:lang="en">Yan Z., Yuan Z., Ni J., Gu L., Shen Y. Crystal structure of the crenarchaeal ExoIII AP endonuclease SisExoIII reveals a conserved disulfide bond endowing the protein with thermostability. Biochem Biophys Res Commun. 2017. 490(3). 774-779. DOI: 10.1016/j.bbrc.2017.06.116.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Esadze A., Rodriguez G., Cravens S.L., Stivers J.T. AP-Endonuclease 1 Accelerates Turnover of Human 8-Oxoguanine DNA Glycosylase by Preventing Retrograde Binding to the Abasic-Site Product. Biochemistry. 2017. 56(14). 1974-1986. DOI: 10.1021/acs.biochem.7b00017.</mixed-citation><mixed-citation xml:lang="en">Esadze A., Rodriguez G., Cravens S.L., Stivers J.T. AP-Endonuclease 1 Accelerates Turnover of Human 8-Oxoguanine DNA Glycosylase by Preventing Retrograde Binding to the Abasic-Site Product. Biochemistry. 2017. 56(14). 1974-1986. DOI: 10.1021/acs.biochem.7b00017.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lai Y., Jiang Z., Zhou J., Osemota E., Liu Y. AP endonuclease 1 prevents the extension of a T/G mismatch by DNA polymerase β to prevent mutations in CpGs during base excision repair. DNA Repair (Amst). 2016. 43. 89-97. DOI: 10.1016/j.dnarep.2016.03.006.</mixed-citation><mixed-citation xml:lang="en">Lai Y., Jiang Z., Zhou J., Osemota E., Liu Y. AP endonuclease 1 prevents the extension of a T/G mismatch by DNA polymerase β to prevent mutations in CpGs during base excision repair. DNA Repair (Amst). 2016. 43. 89-97. DOI: 10.1016/j.dnarep.2016.03.006.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ito H., Matsuo K., Hamajima N., et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis. 2004. 25(8). 1395-1401. DOI: 10.1093/carcin/bgh153.</mixed-citation><mixed-citation xml:lang="en">Ito H., Matsuo K., Hamajima N., et al. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis. 2004. 25(8). 1395-1401. DOI: 10.1093/carcin/bgh153.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
